CHIT1 and anemia (phenotype): ERT has been proven safe and effective for visceromegaly, anemia, thrombocytopenia, and skeletal symptoms related to GD [1, 3–6], and it reduces the blood levels of the acid phosphatase, ACE, and chitotriosidase biomarkers [7].